David Einhorn - Greenlight Capital Portfolio Performance Analysis (Q2 2026)
Investment performance metrics based on historical 13F filings data.
Data Coverage: December 2025 to June 2026 • Initial Portfolio Value: $2.79B
Performance calculated from first filing in our database. This may not represent the investor's entire career.
Portfolio Growth (Since First Filing)
+0.74B
+26.56%
Winning Positions
+42.31%
22 wins / 52 positions
Average Gain (Winners)
$32.88M
+252.90% avg per position
Active Positions
40
17 losing positions
Portfolio Value Over Time
Total Positions Tracked
52
All holdings over time
Win/Loss Ratio
1.29
22 gains / 17 losses
Active vs. Exited
40 / 12
Current positions / Exited
Position Performance
Performance calculated from first appearance in 13F filings. Initial values represent position value when first tracked, not actual purchase prices.
| Symbol | Company | Sector | Entry | Status | Initial Value | Current Value | Gain/Loss | Return % |
|---|---|---|---|---|---|---|---|---|
| GRBK | Green Brick Partners, Inc. | Consumer Cyclical | Dec 2025 | ACTIVE | $593.23M | $757.77M | $164.54M | +27.74% |
| SNX | TD SYNNEX Corporation | Technology | Dec 2025 | ACTIVE | $8.49M | $101.87M | $93.38M | +1100.35% |
| ACHC | Acadia Healthcare Company, Inc. | Healthcare | Dec 2025 | ACTIVE | $58.48M | $129.95M | $71.47M | +122.21% |
| SHC | Sotera Health Company | Healthcare | Dec 2025 | ACTIVE | $8.14M | $73.41M | $65.27M | +802.14% |
| PTON | Peloton Interactive, Inc. | Consumer Cyclical | Dec 2025 | EXITED | $1.52M | $43.39M | $41.87M | +2757.92% |
| PENN | PENN Entertainment, Inc. | Consumer Cyclical | Dec 2025 | ACTIVE | $89.16M | $125.18M | $36.02M | +40.40% |
| G76279101 | Roivant Sciences | N/A | Dec 2025 | ACTIVE | $44.90M | $76.18M | $31.28M | +69.66% |
| AXL | American Axle & Manufacturing H | Consumer Cyclical | Mar 2026 | ACTIVE | $37.43M | $67.18M | $29.76M | +79.50% |
| CROX | Crocs, Inc. | Consumer Cyclical | Mar 2026 | ACTIVE | $55.55M | $80.73M | $25.17M | +45.31% |
| HSIC | Henry Schein, Inc. | Healthcare | Dec 2025 | ACTIVE | $35.47M | $60.01M | $24.55M | +69.21% |
Important Note: Data Limitations
These metrics are based on 13F filing data which has significant limitations:
- Quarterly Snapshots Only: 13F filings show positions at quarter-end, not actual transaction prices
- No Transaction Prices: We cannot determine actual buy/sell prices, only end-of-quarter values
- Performance Estimates: Gains/losses are calculated from first appearance to last update using quarterly values
- Missing Data: Intra-quarter trades, dividends, corporate actions, and exact timing are not captured
- Educational Only: These metrics are estimates for understanding general investment patterns, not actual realized returns
Use these metrics for informational and educational purposes only. They represent broad trends, not precise investment performance.